Company Search:
Advanced Search
Sponsored Links
Phylogica Limited Company Snapshot
Phylogica Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Phylogica Limited with three other companies in this sector in Australia: Bioxyne Limited (2017 sales of 2.01 million Australian Dollars [US$1.56 million] ), Factor Therapeutics Ltd (3.07 million Australian Dollars [US$2.38 million] of which 100% was Biotechnology), and Mesoblast Ltd (3.20 million Australian Dollars [US$2.48 million] of which 100% was Mesenchymal Precursor Cell).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Phylogica Limited
  Stock Performance Chart for Phylogica Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): .04
(Figures in Australian Dollars)
1 Week 28.6%   13 Weeks 20.0%  
4 Weeks -10.0%   52 Weeks 0.0%  
Phylogica Limited Key Data:
  Ticker: PYC Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,760,258
(Year Ending Jan 2018).
Employees: 24
  Currency: Australian Dollars Market Cap: 76,878,839
  Fiscal Yr Ends: June Shares Outstanding: 2,135,523,317
  Share Type: Ordinary Closely Held Shares: 1,323,948,282
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.